Health
AstraZeneca effective against Brazil variant – source – Daily Telegraph
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the Brazilian…
Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca is effective against the Brazilian variant of the disease. Colette Luke has more.
Continue Reading
-
Business12 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business8 hours agoDicker Data rides the AI trend to double digit growth
-
Business16 hours agoThis leading broker thinks the CSL share price can climb 40%
-
General21 hours agoDenmark summons US envoy over suspected influence operations in Greenland